Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown Placzek EA; Okamoto Y; Ueda N; Barker ELNeuropharmacology 2008[Dec]; 55 (7): 1095-104Anandamide (AEA) and 2-arachidonyl glycerol (2-AG), endogenous ligands for the CB1 and CB2 cannabinoid receptors, are referred to as endocannabinoids because they mimic the actions of delta9-tetrahydrocannabinol (Delta9-THC), a plant-derived cannabinoid. The processes by which AEA and 2-AG are biosynthesized, released, taken up by cells and hydrolyzed have been of much interest as potential therapeutic targets. In this review we will discuss the progress that has been made to characterize the primary pathways for AEA and 2-AG formation and breakdown as well as the role that specialized membrane microdomains known as lipid rafts play in these processes. Furthermore we will review the recent advances made to track and detect AEA in biological matrices.|Animals[MESH]|Arachidonic Acids/*biosynthesis/metabolism[MESH]|Cannabinoid Receptor Modulators/*biosynthesis/chemistry/metabolism[MESH]|Cell Line[MESH]|Endocannabinoids[MESH]|Fluorescent Antibody Technique[MESH]|Genetic Vectors[MESH]|Glycerides/*biosynthesis/metabolism[MESH]|Humans[MESH]|Mass Spectrometry[MESH]|Membrane Microdomains/metabolism[MESH]|Membranes/chemistry/metabolism[MESH]|Phosphatidylethanolamines/genetics/metabolism[MESH]|Polyunsaturated Alkamides/metabolism[MESH]|Rats[MESH] |
